×

Why investors should be exposed to biotech

5:30 AM ET Mon, 31 March 2014

Jason Kolbert, head of health care research at Maxim Group, says that last week's biotech sell-off was not justified as the sector is going through a "paradigm shift" which should results in higher valuations.